What I think AstraZeneca's purchase of Alexion means for the dividend
What I think AstraZeneca’s purchase of Alexion means for the dividend More on: AstraZeneca(LSE:AZN) recently agreed to buy Alexion Pharmaceuticals for around $39bn. Although management has spoken positively about the deal, AstraZeneca shares initially fell 5.7% to a nine-month low on the news. Given the initial market reaction, here’s what I think the deal means for AstraZeneca’s dividend if it goes through: US$12.3 TRILLION out of thin air… And if you click here we’ll show you som...
Source: fool.co.uk